Evidence map›Paper›PMID 18316157›Full record

ArticleMolecular and cellular endocrinology2008

Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.

Kurt J Sales, Vivien Grant, Henry N Jabbour

Open access · hybridAbstract read
In one paragraph

Article in Molecular and cellular endocrinology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Bioactive lipids and pathological retinal angiogenesis.British journal of pharmacology · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Effects of AFP-172 on COX-2-induced angiogenic activities on human umbilical vein endothelial cells.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2012
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kurt J SalesMRC Human Reproductive Sciences Unit, The Queen's Medical Research Institute, 47 Little France Crescent, Old Dalkeith Road, Edinburgh, United Kingdom.
Vivien Grant
Henry N Jabbour
The Queen's Medical Research Institute · GB

Funding

Medical Research Council MC_U127684438Medical Research Council U.1276.00.004.00002.01/2(61014)
6 · The paper itself

Abstract

In endometrial adenocarcinomas COX-2 and F-series prostanoid (FP) receptor expression and prostanoid biosynthesis (PGE(2) and PGF(2alpha)) are elevated. In the present study, we investigated the effect of PGE(2) and PGF(2alpha) on the expression of COX-2 via the FP receptor in endometrial adenocarcinoma cells stably expressing the FP receptor (FPS cells). Using chemical inhibitors of intracellular signaling pathways, reporter gene assays and quantitative RT-PCR analysis, we show that PGE(2) and PGF(2alpha) can mobilize inositol 1,4,5-trisphosphate, induce ERK1/2 phosphorylation via the phospholipase Cbeta-protein kinase A-epidermal growth factor receptor pathway and induce cyclooxygenase-2 (COX-2) expression via the FP receptor. In addition we show that the PGE(2) or PGF(2alpha)-regulation of COX-2 via the FP receptor is mediated via the cAMP response element (CRE) binding site on the COX-2 promoter. These data indicate that PGE(2) and PGF(2alpha) biosynthesized locally within endometrial adenocarcinomas can regulate tumor cell function in an autocrine/paracrine manner via the FP receptor.

Indexed as

Gene Expression Regulation, EnzymologicResponse ElementsAdenocarcinomaCell Line, TumorCyclooxygenase 2DinoprostDinoprostoneEndometrial NeoplasmsEnzyme ActivationEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesFemaleGenes, ReporterHumansInositol 1,4,5-TrisphosphatePromoter Regions, Genetic6-isopropoxy-9-oxoxanthene-2-carboxylic acidAL 8810Cyclooxygenase 2DinoprostDinoprostoneEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesInositol 1,4,5-TrisphosphateProstaglandin Antagonistsprostaglandin F2alpha receptorPTGS2 protein, humanReceptors, ProstaglandinReceptors, Prostaglandin EXanthones

Identifiers

PMID18316157
PMCPMC2694994
OpenAlexW2088426128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.